News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
Katabi Maha
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 06/08/2023 |
4
| Katabi Maha (10% Owner) has filed a Form 4 on Aerovate Therapeutics, Inc.|
Txns:
| Granted 12,500 options to buy
@ $16.3, valued at
$203.8k
|
|
| 05/12/2023 |
4
| Katabi Maha (Director) has filed a Form 4 on Vera Therapeutics, Inc.|
Txns:
| Granted 20,000 options to buy
@ $7.7, valued at
$154k
|
|
| 02/27/2023 |
4
| HEALY JAMES (10% Owner) has filed a Form 4 on CinCor Pharma, Inc.|
Txns:
| Sold 6,000 shares
@ $14.32, valued at
$85.9k
Unknown transaction of 9,803 shares
@ $0
Disposed/sold 19,608 shares
@ $0
Unknown transaction of 6,073,949 shares
@ $0 |
|
| 02/08/2023 |
4
| Sofinnova Venture Partners X, L.P. (10% Owner) has filed a Form 4 on Vera Therapeutics, Inc.|
Txns:
| Bought 285,714 shares
@ $7, valued at
$2M
|
|
| 01/05/2023 |
4
| Katabi Maha (10% Owner) has filed a Form 4 on Aerovate Therapeutics, Inc.|
Txns:
| Granted 2,627 options to buy
@ $27.03, valued at
$71k
|
|
| 08/15/2022 |
4
| Sofinnova Venture Partners X, L.P. (10% Owner) has filed a Form 4 on CinCor Pharma, Inc.|
Txns:
| Bought 500,000 shares
@ $30, valued at
$15M
|
|
| 06/22/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/26/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/14/2022 |
4
| Sofinnova Venture Partners X, L.P. (10% Owner) has filed a Form 4 on Vera Therapeutics, Inc.|
Txns:
| Bought 266,666 shares
@ $15, valued at
$4M
|
|
| 01/13/2022 |
4
| Sofinnova Venture Partners X, L.P. (10% Owner) has filed a Form 4 on CinCor Pharma, Inc.|
Txns:
| Converted 5,248,949 shares
@ $0
Bought 325,000 shares
@ $16, valued at
$5.2M
Converted 13,571,428 preferred shares
@ $0
Converted 4,275,000 preferred shares
@ $0 |
|
| 01/06/2022 |
3
| Sofinnova Venture Partners X, L.P. (10% Owner) has filed a Form 3 on CinCor Pharma, Inc. |
| 01/05/2022 |
4
| Katabi Maha (10% Owner) has filed a Form 4 on Aerovate Therapeutics, Inc.|
Txns:
| Granted 7,240 options to buy
@ $10.93, valued at
$79.1k
|
|
| 07/06/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/01/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/29/2021 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 05/18/2021 |
4
| Katabi Maha (10% Owner) has filed a Form 4 on Vera Therapeutics, Inc.|
Txns:
| Converted 2,187,504 shares
@ $0
Bought 727,272 shares
@ $11, valued at
$8M
Converted 2,187,504 preferred shares
@ $0 |
|
| 05/17/2021 |
4
| Katabi Maha (10% Owner) has filed a Form 4 on Vera Therapeutics, Inc.|
Txns:
| Granted 9,925 options to buy
@ $11, valued at
$109.2k
|
|
| 05/13/2021 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 02/09/2021 |
4
| Sofinnova Venture Partners X, L.P. (10% Owner) has filed a Form 4 on Bolt Biotherapeutics, Inc.|
Txns:
| Converted 1,104,209 shares
@ $0
Converted 1,200,228 shares
@ $0
Bought 450,000 shares
@ $20, valued at
$9M
Converted 1,104,209 preferred shares
@ $0
Converted 1,200,228 preferred shares
@ $0 |
|
| 02/04/2021 |
3
| Sofinnova Venture Partners X, L.P. (10% Owner) has filed a Form 3 on Bolt Biotherapeutics, Inc. |
| 07/28/2020 |
4
| Sofinnova Venture Partners X, L.P. (10% Owner) has filed a Form 4 on Inozyme Pharma, Inc.|
Txns:
| Converted 1,590,808 shares
@ $0
Bought 437,500 shares
@ $16, valued at
$7M
Converted 11,888,112 convertible preferred
@ $0 |
|
| 07/23/2020 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 07/01/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
|
|